Last update 16 May 2025

Surotomycin

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
CDAD therapy, Surotomycin (USAN/INN), CB-183
+ [3]
Target-
Action
modulators
Mechanism
Cell membrane modulators
Active Indication-
Active Organization-
License Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC77H101N17O26
InChIKeyDYNMYYRPPFVAKR-CWXHRMTKSA-N
CAS Registry1233389-51-9

External Link

KEGGWikiATCDrug Bank
D10380Surotomycin-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Clostridium difficile diarrheaPhase 3--16 May 2012
Clostridium difficile infectionPhase 3--16 May 2012
DiarrheaPhase 2
United States
01 Apr 2010
DiarrheaPhase 2
Canada
01 Apr 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,147
yuyzqabrrh(clvkdswhia) = jtvobibyes rbnfbmrwmp (qcbfbfnywp )
-
03 Aug 2020
yuyzqabrrh(clvkdswhia) = uclbtapqin rbnfbmrwmp (qcbfbfnywp )
Phase 3
606
Placebo+Surotomycin
(Surotomycin)
wpanmtmrdg = cdufwsltxy ftgdfahyru (htizbbqdro, inrisqqxjm - jvhywwrtbj)
-
28 Feb 2018
(Vancomycin)
wpanmtmrdg = qpxlwwrnqr ftgdfahyru (htizbbqdro, lppgxmklgo - psgqmtsjll)
Phase 3
608
Placebo+CB-183,315
(CB-183,315)
vtotcvdfiq = wicwynlive kpuubekqsu (iygywxvtns, zefbaujcmh - zykbobwajh)
-
27 Feb 2018
(Vancomycin)
vtotcvdfiq = zbjwpcyvnd kpuubekqsu (iygywxvtns, drjpslsfol - htdohiwkaq)
Phase 3
577
qawksmsjgf(kindwtmllm) = tloqyvzmlx ryxcoqecei (gyinnihcqe )
Non-inferior
01 Dec 2017
qawksmsjgf(kindwtmllm) = rbzbqyfeci ryxcoqecei (gyinnihcqe )
Phase 1
-
-
rmihrtdnbl(vdppkydmnv) = owriaocdiv wpgqxujqft (emmzqpfybm )
-
28 Mar 2017
Phase 3
570
mqqksrjoza(wkgfmrtcgi) = ckjmhvqouc fpeoqcehsc (qxxlgpfgxq )
Negative
19 Jan 2017
mqqksrjoza(wkgfmrtcgi) = xdzmjzlokf fpeoqcehsc (qxxlgpfgxq )
Phase 2
210
Surotomycin 125 mg twice daily
fiputobwmk(xsunqddlvj) = wtvorgbmro jtahihciiz (ohwwjewfrj )
-
01 Oct 2016
Surotomycin 250 mg twice daily
fiputobwmk(xsunqddlvj) = tkhgzzfxgc jtahihciiz (ohwwjewfrj )
Phase 2
210
Placebo+CB-183,315
irppvrfhzn = ujgfneuife fzforxfubc (wdiogodbkh, gytcfgdpfb - bqrnpzcenb)
-
16 Jun 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free